The peritoneal cavity, which contains the abdominal organs, is a less common but still potential site for breast cancer to ...
A 66-year-old male patient underwent surgery for prostate cancer 4 years ago. His initial prostate-specific antigen (PSA) ...
The ReSPECT-LM single-dose escalation trial assessed the safety, tolerability, and potential efficacy of intrathecally administered Rhenium ( 186 Re) Obisbemeda in patients with leptomeningeal ...
On CTMX's fourth-quarter 2024 earnings call, investors can expect updates regarding the developmental programs for its clinical-stage candidates.
An Australian-grown discovery has collared the culprit causing deadly ovarian cancer to return and spread after treatment.
APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and a presentation by Dr.
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics ...
Editor's note: The attached video features footage from the 2024 Race for the Cure. Sign up before May 12 ...
AI holds immense promise but also demands a careful, measured approach to yield the greatest benefit—especially for cancer ...
5don MSN
The retired NBA star revealed last month he had 40% of his kidney removed after doctors discovered a tumor. Here's what you ...
A former university employee accused of accessing a breast cancer study database and changing patient information “hours ...
5d
Health on MSNWhat To Know About HR+/HER2- Breast CancerHR+/HER2- breast cancer involves cells that test positive for hormone receptors and negative for HER2 proteins. It's the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results